[1]Patent:WO2009/80705,2009,A2,.Locationinpatent:Page/Pagecolumn52
[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,#17,p.3569-3574
[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,#17,p.3569-3574
[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,#17,p.3569-3574
[1]Patent:WO2009/80705,2009,A2.Locationinpatent:Page/Pagecolumn52
[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.3569-3574
[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.3569-3574
[1]BioorganicandMedicinalChemistryLetters,2015,vol.25,p.3569-3574
Title: Jamieson S, et al. A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types. Biochem J, 2011, 438(1), 53-62.
Title: Sun M, et al. Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha. Proc Natl Acad Sci U S A, 2010, 107(35), 15547-15552.
